期刊文献+

Impact of comorbidities on the severity of chronic hepatitis B at presentation 被引量:8

Impact of comorbidities on the severity of chronic hepatitis B at presentation
在线阅读 下载PDF
导出
摘要 AIM:To evaluate the clinical relevance of each cofactor on clinical presentation of chronic hepatitis B.METHODS:Out of 1366 hepatitis B surface antigen(HBsAg) positive subjects consecutively observed in 79 Italian hospitals,53(4.3%) showed as the only cofactor hepatitis D virus(HDV) infection [hepatitis B virus(HBV)/HDV group],130(9.5%) hepatitis C virus(HCV)(group HBV/HCV),6(0.4%) human immunodeficiencyvirus(HIV)(group HBV/HIV),138(10.2%) alcohol abuse(group HBV/alcohol);109(8.0%) subjects had at least two cofactors and 924 were in the cofactor-free(CF) group.RESULTS:Compared with patients in group CF those in group HBV/alcohol were older and more frequently had cirrhosis(P < 0.001),those in group HBV/HDV were younger(P < 0.001),more frequently resided in the south of the country and had cirrhosis(P <0.001),those in group HBV/HCV were older(P < 0.001) and more frequently had cirrhosis(P < 0.001).These cofactors were all independent predictors of liver cirrhosis in HBsAg positive patients.Multivariate analysis showed that an older age [odds ratio(OR) 1.06,95% CI:1.05-1.08],alcohol abuse with more than 8 drinks daily(OR 2.89,95% CI:1.81-4.62) and anti-HDV positivity(OR 3.48,95% CI:2.16-5.58) are all independently associated with liver cirrhosis.This association was found also for anti-HCV positivity in univariate analysis,but it was no longer associated(OR 1.23,95% CI:0.84-1.80) at multivariate analysis.CONCLUSION:Older age,HDV infection and alcohol abuse are the major determinants of severe liver disease in chronic HBV infection,while HCV replication plays a lesser role in the severity of hepatic damage. AIM:To evaluate the clinical relevance of each cofactor on clinical presentation of chronic hepatitis B.METHODS:Out of 1366 hepatitis B surface antigen(HBsAg) positive subjects consecutively observed in 79 Italian hospitals,53(4.3%) showed as the only cofactor hepatitis D virus(HDV) infection [hepatitis B virus(HBV)/HDV group],130(9.5%) hepatitis C virus(HCV)(group HBV/HCV),6(0.4%) human immunodeficiencyvirus(HIV)(group HBV/HIV),138(10.2%) alcohol abuse(group HBV/alcohol);109(8.0%) subjects had at least two cofactors and 924 were in the cofactor-free(CF) group.RESULTS:Compared with patients in group CF those in group HBV/alcohol were older and more frequently had cirrhosis(P 0.001),those in group HBV/HDV were younger(P 0.001),more frequently resided in the south of the country and had cirrhosis(P 0.001),those in group HBV/HCV were older(P 0.001) and more frequently had cirrhosis(P 0.001).These cofactors were all independent predictors of liver cirrhosis in HBsAg positive patients.Multivariate analysis showed that an older age [odds ratio(OR) 1.06,95% CI:1.05-1.08],alcohol abuse with more than 8 drinks daily(OR 2.89,95% CI:1.81-4.62) and anti-HDV positivity(OR 3.48,95% CI:2.16-5.58) are all independently associated with liver cirrhosis.This association was found also for anti-HCV positivity in univariate analysis,but it was no longer associated(OR 1.23,95% CI:0.84-1.80) at multivariate analysis.CONCLUSION:Older age,HDV infection and alcohol abuse are the major determinants of severe liver disease in chronic HBV infection,while HCV replication plays a lesser role in the severity of hepatic damage.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第14期1616-1621,共6页 世界胃肠病学杂志(英文版)
基金 Supported by A grant from the Progetto di Ricerca di Interesse Nazionale 2000 in part with a grant from the Viral Hepatitis Project Istituto Superiore di Sanità,D.leg.vo 30/12/1992 n.502
关键词 Chronic hepatitis B Hepatitis B virus/hepatitis D virus dual infection Hepatitis B virus/hepatitis C virus dual infection Alcohol abuse 慢性乙型肝炎 合并症 乙肝表面抗原 乙型肝炎病毒 丙型肝炎病毒 病毒感染 多元统计分析 临床意义
  • 相关文献

参考文献26

  • 1Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1154 cases. A report from the study group for CAH of the Italian Association for the Study of the Liver. Hepatogastroenterology 1983; 30: 126-130.
  • 2Giusti G,Galanti B,Gaeta GB,Sagnelli E,Piccinino F,Ruggiero G. Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases. Ital J Gastroenterol 1991; 23: 111-118.
  • 3Giusti G,Sagnelli E,Gallo C,Piccinino F,Galanti B,Gaeta GB. The etiology of chronic hepatitis in Italy: a multicenter study. Hepatogastroenterology 1994; 41: 397-400.
  • 4Sagnelli E,Stroffolini T,Mele A,Almasio P,Coppola N, Ferrigno L,Scolastico C,Onofrio M,Imparato M,Filippini P. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol 2005; 75: 522-527.
  • 5De Bac C,Stroffolini T,Gaeta GB,Taliani G,Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994; 20: 1225-1230.
  • 6Soriano V,Puoti M,Peters M,Benhamou Y,Sulkowski M, Zoulim F,Mauss S,Rockstroh J. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008; 22: 1399-1410.
  • 7Piroth L,Sène D,Pol S,Goderel I,Lacombe K,Martha B, Rey D,Loustau-Ratti V,Bergmann JF,Pialoux G,Gervais A, Lascoux-Combe C,Carrat F,Cacoub P. Epidemiology,diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS 2007; 21: 1323-1331.
  • 8Ribes J,Clèries R,Rubió A,Hernández JM,Mazzara R, Madoz P,Casanovas T,Casanova A,Gallen M,Rodríguez C, Moreno V,Bosch FX. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 2006; 119: 687-694.
  • 9Manno M,Cammà C,Schepis F,Bassi F,Gelmini R,Giannini F,Miselli F,Grottola A,Ferretti I,Vecchi C,De Palma M, Villa E. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004; 127: 756-763.
  • 10Sun CA,Wu DM,Lin CC,Lu SN,You SL,Wang LY,Wu MH,Chen CJ. Incidence and cofactors of hepatitis C virusrelated hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003; 157: 674-682.

同被引文献45

  • 1Abeer Elkady,Sahar Aboulfotuh,Elsayed Mostafa Ali,Douaa Sayed,Nashwa M Abdel-Aziz,Amany M Ali,Shuko Murakami,Sayuki Iijima,Yasuhito Tanaka.Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt[J].World Journal of Gastroenterology,2013,19(37):6214-6220. 被引量:8
  • 2Di-PengOu Lian-YueYang Geng-WenHuang Yi-MingTao XiangDing Zhi-GangChang.Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV[J].World Journal of Gastroenterology,2005,11(14):2061-2066. 被引量:12
  • 3Wang J, Guo L, Shi X, et al. Real-time elastography with a novel quantitative technology for assessment of liver fibrosis in chronic hepatitis B [ J ]. European Journal of Radiology, 2012,81 ( 1 ) : e31 -e36.
  • 4Liu A, Ha NB, Lin B, et al. Low hepatitis B envelope antigen serocon- version rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice[ J]. European journal of gastroen- terology and hepatology,2013,25 (3) :338-343.
  • 5Yi-Hsiang Huang,Liang-Tsai Hsiao,Ying-Chung Hong,Tzeon-Jye Chiou,Yuan-Bin Yu,Jyh-Pyng Gau,Chun-Yu Liu,Muh-Hwa Yang,Cheng-Hwai Tzeng,Pui-Ching Lee,Han-Chieh Lin,Shou-Dong Lee.Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B[J].Journal of Clinical Oncology.2013(22)
  • 6Hua-Jie Dong,Ling-Na Ni,Gui-Feng Sheng,Hong-Lei Song,Jian-Zhong Xu,Yang Ling.Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis[J].Journal of Clinical Virology.2013(3)
  • 7Seok Jin Kim,Chiun Hsu,Yu-Qin Song,Kevin Tay,Xiao-Nan Hong,Junning Cao,Jin Seok Kim,Hyeon Seok Eom,Joon Hyeok Lee,Jun Zhu,Kian-Meng Chang,Arry Harryanto Reksodiputro,Daryl Tan,Yeow Tee Goh,Jejung Lee,Tanin Intragumtornchai,Wee-Joo Chng,Ann-Lii Cheng,Soon Thye Lim,Cheolwon Suh,Yok-Lam Kwong,Won Seog Kim.Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group[J].European Journal of Cancer.2013
  • 8Carlo Saitta,Cristina Musolino,Grazia Marabello,Daniela Martino,Maria Silvana Leonardi,Teresa Pollicino,Giuseppe Altavilla,Giovanni Raimondo.Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy[J].Digestive and Liver Disease.2013
  • 9Nicola Coppola,Giovanna Loquercio,Gilda Tonziello,Rosa Azzaro,Mariantonietta Pisaturo,Gaetano Di Costanzo,Mario Starace,Giuseppe Pasquale,Carmela Cacciapuoti,Arnolfo Petruzziello.HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient[J].Journal of Clinical Virology.2013
  • 10Gilda Tonziello,Marintonietta Pisaturo,Antonello Sica,Maria Giovanna Ferrara,Caterina Sagnelli,Giuseppe Pasquale,Evangelista Sagnelli,Salvatore Guastafierro,Nicola Coppola.Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma[J].Infection.2013(1)

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部